On October 18, 2018, CMS issued a new proposed rule that would require direct-to-consumer (DTC) television advertisements of prescription drugs and biological products payable by Medicare or Medicaid to include the wholesale acquisition cost (WAC), or list price, of that prescription drug or biological product.
On October 18, 2018, the Centers for Medicare & Medicaid Services (CMS) issued a new proposed rule entitled Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency.
October 2018 News & Views: Partnership Forum Eyes Roadmap to Integrate Medical & Pharmacy Data; CEO Blog: The Patient’s Paramount Place New at Nexus 2018!; AMCP Talks: Solutions for Value-Based Care
Leg-Reg Briefing October 2018: CMS Releases Star Ratings for 2019 Part D Plans; New Proposed Rule on Drug Prices in DTC TV Ads; House, Senate Recess Until After Midterms
AMCP CEO Blog: As managed care pharmacy professionals, we work to improve the lives of millions of people. But we also must never forget that behind these large numbers are individual patients.